GLP-1, Amylin Analog Combo Cuts Blood Sugar, Weight in Diabetes Trials

(MedPage Today) -- NEW ORLEANS -- A fixed-dose combination of novel amylin analog cagrilintide and semaglutide, given once weekly, lowered blood glucose and weight in various populations with type 2 diabetes. The combination injectable, dubbed...
Source
MedPage Today
Opens original article in a new tab



